Results 251 to 260 of about 218,415 (311)
Impact of Comprehensive Education on Antibiotic Duration of Therapy for Community-Acquired Pneumonia in a Community Hospital. [PDF]
Prebble K, Marefat L.
europepmc +1 more source
Relationship Between Swallowing Frequency and Swallowing‐Related Muscle Mass in Older Adults
The relationship between swallowing frequency and geniohyoid muscles was investigated. We show the positive correlation between them. ABSTRACT Background Older adults have decreased swallowing‐related muscle mass, which may lead to decreased swallowing function.
Haruna Kawamichi +4 more
wiley +1 more source
This study examined the effects of dental treatments on the recovery of oral function in patients with subacute stroke in convalescent rehabilitation. The findings highlight the importance of dental treatments during stroke recovery. ABSTRACT Background Compromised oral function in patients with stroke hinders the recovery of oral food intake and ...
Koichiro Matsuo +7 more
wiley +1 more source
Corticosteroids in bacterial severe community-acquired pneumonia: lessons from recent trials. [PDF]
Nguyen TL +5 more
europepmc +1 more source
Infrared Spectroscopy as a Promising Tool for Diagnosing and Typing Human Pathogenic Fungi
ABSTRACT Fungal infections are increasingly recognised as a global health challenge, responsible for millions of cases annually and substantial mortality, especially in immunocompromised individuals. Yet, the diagnosis of these infections remains notoriously difficult, often delayed by slow culture‐based methods or hindered by the high cost and ...
Anthony G. J. Medeiros +8 more
wiley +1 more source
A polymorphism of DSP was associated with prognosis and acute exacerbation in Japanese individuals with idiopathic pulmonary fibrosis (IPF), and a polymorphism of TERT was associated with prognosis in the patients with IPF and acute exacerbation in those with unclassifiable idiopathic interstitial pneumonias, indicating the potential of personalised ...
Kazuya Tsubouchi +18 more
wiley +1 more source
Inhaled Ciclesonide for Community‐Based COVID‐19: A Placebo‐Controlled Randomised Trial
We undertook a double‐blind, placebo‐controlled, randomised community trial of inhaled ciclesonide 320 mcg daily or placebo for 14 days. The primary outcome was time to recovery of symptoms to day 28. There were 189 people randomised and 185 completed treatment; 96% were COVID‐19 vaccinated.
Peter Wark +12 more
wiley +1 more source

